Molecular Devices Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Molecular Devices Corporation's estimated annual revenue is currently $145.1M per year.
- Molecular Devices Corporation's estimated revenue per employee is $155,000
Employee Data
- Molecular Devices Corporation has 936 Employees.
- Molecular Devices Corporation grew their employee count by -6% last year.
Molecular Devices Corporation's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Assistant to the VP Global Sales | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP Global Marketing and Product Management | Reveal Email/Phone |
4 | VP Global Sales and Service | Reveal Email/Phone |
5 | VP, Global Danaher Business Systems | Reveal Email/Phone |
6 | VP Global Operations | Reveal Email/Phone |
7 | VP Drug Discovery, Western Markets | Reveal Email/Phone |
8 | Director Commercial Business Development | Reveal Email/Phone |
9 | Director Finance | Reveal Email/Phone |
10 | Director Sales, Applications and Service, Drug Discovery Europe | Reveal Email/Phone |
Molecular Devices Corporation Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Molecular Devices Corporation?
Molecular Devices Corp. (MDC) is a developer of high-performance, bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The Company's systems enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high throughput and cost effective identification and evaluation of drug candidates. The Company's instrument systems are based on its advanced core technologies which integrate its experience in engineering, molecular and cell biology and chemistry. The Company currently offers three product families that address different segments of the drug discovery market: the MAXline family of microplate readers, the Cell Analysis products (which include the Fluorometric Imaging Plate Reader, or FLIPR, system, the Chemiluminescence Imaging Plate Reader, or CLIPR, system and the Cytosensor system), and theThreshold system. (Source: 10-K)
keywords:N/A
N/A
Total Funding
936
Number of Employees
$145.1M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Molecular Devices Corporation News
... Microscopes Market 2022 Segments Analysis by Top Key Players : CarlZeiss, Leica Microsystems, Nikon Corporation, Molecular Devices.
(MDS Analytical Technologies, Inc.), Carl-Zeiss-Stiftung, Leica Microsystems (Danaher Corporation), Molecular Devices, LLC., Becton, Dickinson...
Molecular Devices, LLC., a leading provider of high-performance life science solutions and a company of Danaher Corporation (NYSE:DHR),...
Organoid Innovation Center at Molecular Devices By allowing real-time feedback on 3D model development and providing greater confidence with standardized, more consistent protocols with precise timing of each step in the process, we’ve removed significant barriers to allow shorter time to discov ...
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $285.5M | 971 | 7% | N/A |
#2 | $193.8M | 989 | 12% | N/A |
#3 | $1100M | 997 | 9% | N/A |
#4 | $75M | 997 | 6% | N/A |
#5 | $206.7M | 1018 | 5% | N/A |